Cost Effectiveness of Cryptococcal Antigen Screening as a Strategy to Prevent HIV-Associated Cryptococcal Meningitis in South Africa

• Joseph N. Jarvis ,

  * E-mail: joejarvis@doctors.net.uk

  Affiliations Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom, Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa, Research Centre for Infection and Immunity, Division of Clinical Sciences, St. George’s University of London, London, United Kingdom

  ⨯
• Thomas S. Harrison,

  Affiliation Research Centre for Infection and Immunity, Division of Clinical Sciences, St. George’s University of London, London, United Kingdom

  ⨯
• Stephen D. Lawn,

  Affiliations Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom, Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa

  ⨯
• Graeme Meintjes,

  Affiliations Department of Medicine, University of Cape Town, Cape Town, South Africa, Clinical Infectious Diseases Research Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa, Department of Medicine, Imperial College London, London, United Kingdom

  ⨯
• Robin Wood,

  Affiliations Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa, Department of Medicine, University of Cape Town, Cape Town, South Africa

  ⨯
• Susan Cleary

  Affiliation Health Economics Unit, University of Cape Town, Cape Town, South Africa

  ⨯